(Q47588177)

4 February 2018

title

P-27/HP endolysin as antibacterial agent for antibiotic resistant Staphylococcus aureus of human infections (English)

1 reference

4 February 2018

main subject

antibiotic resistance

1 reference

inferred from title

Staphylococcus aureus

1 reference

Ragini Gupta

1

1 reference

4 February 2018

Yogendra Prasad

series ordinal

2

1 reference

4 February 2018

publication date

27 April 2011

1 reference

4 February 2018

published in

Current Microbiology

1 reference

4 February 2018

volume

63

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

39-45

1 reference

4 February 2018

Experimental phage therapy against Staphylococcus aureus in mice

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Community-associated MRSA--resistance and virulence converge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Taking aim on bacterial pathogens: from phage therapy to enzybiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Phage Therapy in Clinical Practice: Treatment of Human Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Bacteriophage endolysins--current state of research and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Antimicrobial resistance: the example of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Antimicrobial activity of a chimeric enzybiotic towards Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Bacteriophage and their lysins for elimination of infectious bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Orphan drugs of the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Phage P68 virion-associated protein 17 displays activity against clinical isolates of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00284-011-9939-8

Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides

21 January 2018

1 reference

12 December 2020

Staphylococcal bacteriophage-associated lysin: a lytic agent active against Staphylococcus aureus

1 reference

12 December 2020

Bacteriophage endolysins as a novel class of antibacterial agents.

1 reference

12 December 2020

Efficacy of polyvalent bacteriophage P-27/HP to control multidrug resistant Staphylococcus aureus associated with human infections

1 reference

12 December 2020

Bacteriophage therapy for the treatment of infections.

1 reference

12 December 2020

10.1007/S00284-011-9939-8

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018